An Open-label Multiple-Dose Study to Evaluate the Pharmacokinetics, Safety, andTolerability of Upadacitinib in Pediatric Subjects with Severe Atopic Dermatitis

Project: Research project

Project Details

StatusActive
Effective start/end date12/23/198/31/50

Funding

  • Northwestern University
  • AbbVie Inc.